All posts tagged
How the CRISPR-Cas9 System is Redefining Drug Discovery
FDA Speeds Up the Approval Process for Bayer’s New Lymphoma Drug
What’s Berlin’s Secret to Success in Biotech & Digital Health?
Which European Blockbusters Topped the Charts in 2016?
Epigenetics Drug Improves Survival in the Second Deadliest Cancer
The Largest Deals, Fundraising and Exits of 2016 in European Biotech
UPDATE: Bayer seals deal with Monsanto in Dark Side slide
European Pharma closes 2016 by launching new Biotech Startups
UPDATE: Cold Sore Season is Here! AiCuris might have a Herpes Cure
Another Brexit Siren Sounds: GSK’s CEO weighs in on the EMA’s (Re)Location
BOOOOO! What about a career at Novozymes, AstraZeneca or Evolva?
German Record-deal Antiviral drug Succeeds in Phase III
Labiotech UG, All Rights Reserved -
Send this to friend